Candela Introduces New Pulsed Dye Laser Platform; New Models Offer Flexible Solutions for Helping Patients Achieve Better Looking Skin.

WAYLAND, Mass. -- Candela Corporation (NASDAQ: CLZR) today announced the introduction of a new Pulsed Dye Laser Platform featuring three new models - the Aesthetica, the Platinum and the Perfecta. Practitioners will now be able to choose from three product configurations to treat patients looking for skin rejuvenation, removal of brown sun spots, leg and facial veins, facial redness, treatment of rosacea and much more. Customers can easily upgrade to the next version of the product to add more applications as their practices grow. With over twenty clinical applications, this new platform offers the widest range of treatment applications available on the market today.

"Our Pathways program enables our customers to choose from a wide range of technology and product configurations to match the needs of their businesses," said Gerard E. Puorro, President and Chief Executive Officer of Candela. "With the addition of our new Pulsed Dye platform, practitioners will have more choices and greater flexibility to meet their individual practice needs and expand their cosmetic treatment offerings to patients."

This new platform is a continuation of the successful Vbeam(R) product line. The new lasers feature a sleek, new look, a simplified user interface, can be customized and are fully upgradeable. The Aesthetica provides optimal rejuvenation results for patients looking to remove both vascular (red) and pigmentation (brown) spots on the skin, while the Platinum is ideal for treating patients with a wide variety of vascular (red) lesions. For practitioners looking for one machine that does it all, the Perfecta is designed for rejuvenation, vascular and pigmented lesions.

Faster and more powerful than other pulsed dye lasers, the new Platform allows practitioners to treat stubborn skin conditions more aggressively than before. With the new "Micro-Pulse" design, practitioners can now perform more aggressive treatments producing faster results without bruising that causes unnecessary downtime for patients.

"The Perfecta represents a significant leap forward in technology. In my opinion, it is the treatment of choice for rejuvenation of skin, removal of linear vessels without bruising, and reduction of pigmented lesions which dramatically improves the overall appearance of photodamaged skin." said Eric Bernstein, M.D., a Clinical Associate Professor of Dermatology at the University of Pennsylvania in Bryn Mawr. "With the new addition of pigmented lesion capability, practitioners can now remove brown spots on the skin with confidence that comes from the well documented safety profile of the pulsed dye laser."

The Aesthetica, Platinum and Perfecta make their debut as part of Candela's Pathways Program, featuring a choice of upgradeable technologies that provide practitioners with the flexibility to treat a wide variety of popular cosmetic skin conditions.

Aesthetica, Platinum & Perfecta feature Candela's unique "Micro-Pulse" technology which enables advanced laser pulsing capability providing improved clinical efficacy. The new "Micro-Pulse" technology enables physicians to improve treatment efficacy without causing unnecessary downtime for patients. The Aesthetica and Perfecta also offer a new pigmented handpiece enabling treatment of brown sun spots and general dyspigmentation. Pigmentation is a very popular clinical indication which is added to the already extensive range of clinical applications including: facial veins, rosacea, facial redness, leg veins, scars, stretch marks, port wine stains, hemangiomas, and warts. Our patented dynamic cooling device (DCD(TM)) is integrated into the device. The DCD is automated to emit cooling spray milliseconds before each laser pulse, which protects the upper layers of the skin from the thermal effects of the laser.

About Candela:

Candela Corporation, an ISO-9001 certified company, develops, manufactures, and distributes innovative clinical solutions that enable physicians, surgeons, and personal care practitioners to treat selected cosmetic and medical conditions using lasers, aesthetic laser systems, and other advanced technologies. Founded near Boston in 1970, the company markets and services its products in over 64 countries from offices and distributors in the United States, Europe, Japan, China and other Asian locations. Candela established the aesthetic laser market 17 years ago, and currently has an installed base of 8,500 lasers worldwide. Candela is an Equal Opportunity and Affirmative Action Employer (Male/Female/Handicapped/Veteran). Visit Candela on the Web at http://www.candelalaser.com.

Safe Harbor Statement: Except for the historical information contained herein, this news release contains forward-looking statements that constitute Candela's current intentions, hopes, beliefs, expectations or predictions of the future, which are therefore inherently subject to risks and uncertainties. Such statements may relate to, among other things, our future revenue, gross margin, expense levels and earnings, our growth prospects, market acceptance of our products, the strength of our distribution channels, our ability to add new products, our ability to expand regulatory approvals and the liquidity of our common stock. The risks and uncertainties that may affect forward-looking statements include, among others: the cancellation or deferral of customer orders, dependence on a small number of strategic distribution relationships, difficulties in the timely development and market acceptance of new products, unanticipated increases in expenses, market developments that vary from the current public expectations concerning the growth of the laser industry, increased competitive pressures, changes in economic conditions, or difficulties in obtaining timely regulatory approvals. Further information on factors that could affect Candela's performance is included in Candela's periodic reports filed with the SEC, including but not limited to, Candela's Annual Report on Form 10-K for the year ended July 2, 2005. Candela cautions readers not to place undue reliance upon any such forward-looking statements, which speak only as of the date made. Candela expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any such statements to reflect any change in Candela's expectations or any change in events, conditions or circumstances on which any such statement is based.